Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$176,316
+$38,351 QoQ
Shares Held
147
-2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#4,442
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Frazier Financial Advisors, LLC holds $5,122,500 across 11 Drug Manufacturers - General names. LLY ranks #3 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
16,576 | $4,171,184 | |
| 2 | JNJ |
Johnson & Johnson
|
1,921 | $487,876 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
147 | $176,316 | |
| 4 | PFE |
Pfizer Inc
|
2,529 | $60,898 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
883 | $50,878 | |
| 6 | NVO |
Novo Nordisk A S
|
935 | $44,823 | |
| 7 | AMGN |
Amgen Inc
|
122 | $44,178 | |
| 8 | NVS |
Novartis AG
|
200 | $31,344 |
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $176,316 | 147 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $137,965 | 150 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $91,347 | 85 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $171,675 | 225 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $201,118 | 258 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $261,813 | 317 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $402,212 | 521 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $489,924 | 553 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $469,892 | 519 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $439,547 | 565 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $238,997 | 410 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||